By vgreene, 29 April, 2020 Terminated early due to low enrollment and control of epidemic in China; no difference in time to clinical improvement (RDV 21 days, placebo 23 days) or 28-day mortality (RDV 14%, placebo 13%); in pts w/ ≤10 days from sx, non-significant difference in tim
By vgreene, 29 April, 2020 Double-blind RCT; 237 pts (median age, 65y) received RDV 200 mg x1, then 100 mg daily x9 days (n=158) or placebo (n=78); incl pts w/ SaO2
By vgreene, 29 April, 2020 Preliminary results: NIH Adaptive COVID-19 Treatment Trial; access NIH news release